↓ Skip to main content

Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.

Overview of attention for article published in Cochrane database of systematic reviews, June 2012
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (85th percentile)
  • Above-average Attention Score compared to outputs of the same age and source (57th percentile)

Mentioned by

blogs
1 blog

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
59 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Intravenous midazolam infusion for sedation of infants in the neonatal intensive care unit.
Published in
Cochrane database of systematic reviews, June 2012
DOI 10.1002/14651858.cd002052.pub2
Pubmed ID
Authors

Ng E, Taddio A, Ohlsson A, Ng, Eugene, Taddio, Anna, Ohlsson, Arne

Abstract

Proper sedation for neonates undergoing uncomfortable procedures may reduce stress and avoid complications. Midazolam is a short-acting benzodiazepine that is increasingly used in neonatal intensive care units (NICU). However, its effectiveness as a sedative in neonates has not been systematically evaluated.

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 59 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Japan 1 2%
Norway 1 2%
Unknown 57 97%

Demographic breakdown

Readers by professional status Count As %
Researcher 12 20%
Student > Ph. D. Student 9 15%
Student > Master 9 15%
Student > Bachelor 7 12%
Other 4 7%
Other 11 19%
Unknown 7 12%
Readers by discipline Count As %
Medicine and Dentistry 27 46%
Pharmacology, Toxicology and Pharmaceutical Science 4 7%
Agricultural and Biological Sciences 3 5%
Psychology 3 5%
Neuroscience 3 5%
Other 8 14%
Unknown 11 19%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 9. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 July 2012.
All research outputs
#3,252,493
of 22,671,366 outputs
Outputs from Cochrane database of systematic reviews
#5,926
of 12,296 outputs
Outputs of similar age
#20,323
of 147,845 outputs
Outputs of similar age from Cochrane database of systematic reviews
#70
of 170 outputs
Altmetric has tracked 22,671,366 research outputs across all sources so far. Compared to these this one has done well and is in the 84th percentile: it's in the top 25% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 12,296 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 30.3. This one has gotten more attention than average, scoring higher than 51% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 147,845 tracked outputs that were published within six weeks on either side of this one in any source. This one has done well, scoring higher than 85% of its contemporaries.
We're also able to compare this research output to 170 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 57% of its contemporaries.